Skip to content
AdaptVac logo

AdaptVac Alternatives & Competitors

12 companies similar to AdaptVac — AdaptVac aims to accelerate the development of safe and efficacious therapeutic...

Companies similar to AdaptVac

ACM Biolabs logo — alternative to AdaptVac
OXFORD VACMEDIX UK LIMITED logo — alternative to AdaptVac

OXFORD VACMEDIX UK LIMITED

Developing therapeutic cancer vaccines using ROP technology

VBI Vaccines Inc. logo — alternative to AdaptVac

VBI Vaccines Inc.

Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease

Rocketvax AG logo — alternative to AdaptVac

Rocketvax AG

Implementing cutting-edge science in next-generation vaccine design that will improve peop...

Rival Readout

Competing with AdaptVac? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout
RemedyBio logo — alternative to AdaptVac

RemedyBio

Remedy is creating a revolution in immune therapeutics though cell-by-cell analysis of imm...

Hawaii Biotech, Inc. logo — alternative to AdaptVac
Memgen, Inc. logo — alternative to AdaptVac

Memgen, Inc.

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

IMUTEX Ltd logo — alternative to AdaptVac

IMUTEX Ltd

A joint venture between SEEK Group and hVIVO, part of Open Orphan plc, to accelerate the d...

Hangzhou ImmuQuad(艾沐蒽) Biotech, LLC. logo — alternative to AdaptVac

Hangzhou ImmuQuad(艾沐蒽) Biotech, LLC.

杭州艾沐蒽生物科技有限公司

Immunaeon logo — alternative to AdaptVac

Immunaeon

Connecting Today's Science to Tomorrow's Cures

Osivax logo — alternative to AdaptVac

Osivax

Pioneering A New Class of Universal Vaccines

Vaxart, Inc. logo — alternative to AdaptVac

Vaxart, Inc.

The pill that moves the needle.

About AdaptVac

AdaptVac is a biotechnology startup with a strong focus on accelerating the development of safe and efficacious therapeutic and prophylactic vaccines. Founded in 2017, the company is a joint-venture between NASDAQ First North listed ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines. The goal of...

Business keywords

Vaccine Development, Therapeutic Vaccines, Prophylactic Vaccines, Infectious Diseases, Cancer Treatment, Immune Therapy, Virus-like Particles, Insect Cell Expression Technology, Biotech, University Of Copenhagen, ExpreS2ion Biotech, NextGen Vaccines, Joint Venture, Immunological Disorders

Frequently Asked Questions

Companies similar to AdaptVac include ACM Biolabs, OXFORD VACMEDIX UK LIMITED, VBI Vaccines Inc., Rocketvax AG, RemedyBio. They work in Biotechnology and Health Care and share AdaptVac's focus on infectious diseases, vaccine development and cancer treatment.
Bounce Watch lists 12 companies that share AdaptVac's industries and are closest to it in business tags, services, target customers, business model and size.
AdaptVac is a biotechnology startup with a strong focus on accelerating the development of safe and efficacious therapeutic and prophylactic vaccines. Founded in 2017, the company is a joint-venture between NASDAQ First North listed ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines. The goal of...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around AdaptVac: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at AdaptVac on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout